Aubrey Rankin, President, Innovation & Technology at Revance Therapeutics, Inc. (RVNC), bought 30,000 shares at $14.43 ($433K) on 2021-12-03, disclosed to the SEC on 2021-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| RVNC | SELL | 2021-07-28 | $3.3M | — | Filing → |
| RVNC | SELL | 2021-04-06 | $57 | — | Filing → |
| RVNC | SELL | 2021-03-05 | $1.7M | — | Filing → |